Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 3/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37528 | 0.93 | — | — | |
| SCHEMBL11506222 | 0.93 | HDAC3 (0.44) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL25238705 | 0.93 | HDAC3 (0.44) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL4293235 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL9687182 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL3244716 | 0.90 | — | — | |
| SCHEMBL21462107 | 0.90 | — | — | |
| SCHEMBL29071751 | 0.87 | — | — | |
| SCHEMBL28614154 | 0.84 | FFAR3 (0.38) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL1412288 | 0.77 | FFAR3 (0.33) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2051861-B1 | POROUS MEMBRANE AND ITS METHOD OF MANUFACTURE | FUJIFILM MFG EUROPE BV (NL) | 2011-03-23 | — | — | EP | claimed |
| EP-4680614-A1 | IMPROVED DIRECT SYNTHESIS OF ALKENYLHALOSILANES | Momentive Performance Materials Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024191735-A1 | IMPROVED DIRECT SYNTHESIS OF ALKENYLHALOSILANES | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2024-09-19 | — | — | WO | disclosed |
| US-20240309024-A1 | DIRECT SYNTHESIS OF ALKENYLHALOSILANES | MOMENTIVE PERFORMANCE MAT INC (US) | 2024-09-19 | — | — | US | disclosed |
| EP-2265359-B1 | PROCESS FOR PREPARING MEMBRANES | FUJIFILM MFG EUROPE BV (NL) | 2017-11-22 | — | — | EP | disclosed |
| US-9290791-B2 | Reagents and methods for sirtuin capture | CORNELL UNIVERSITY (US) | 2016-03-22 | — | — | US | disclosed |
| US-8419838-B2 | Process for preparing membranes | FUJIFILM MANUFACTURING EUROPE B.V. (NL) | 2013-04-16 | — | — | US | disclosed |
| US-20130065248-A1 | REAGENTS AND METHODS FOR SIRTUIN CAPTURE | CORNELL UNIVERSITY (US) | 2013-03-14 | — | — | US | disclosed |
| US-8303691-B2 | Composite membranes | FUJIFILM MANUFACTURING EUROPE B.V. (NL) | 2012-11-06 | — | — | US | disclosed |
| US-8231710-B2 | Membranes and processes for their manufacture and use | FUJIFILM MANUFACTURING EUROPE B.V. (NL) | 2012-07-31 | — | — | US | disclosed |
| US-6362189-B1 | GRAMNEGATIVE, GRAMPOSITIVE BACTERIA | PHARMACIA AND UPJOHN COMPANY | 2002-03-26 | — | — | US | disclosed |
| US-20020016323-A1 | Oxazolidinone antibacterial agents having a thiocarbonyl functionality | PHARMACIA & UPJOHN COMPANY | 2002-02-07 | — | — | US | disclosed |
| US-6342513-B1 | THIOCARBONYLAMIDES ON OXAZO-, ISOOXAZOLE OR FURANONE RINGS FOR USE AS BACTERICIDES | PHARMACIA AND UPJOHN COMPANY | 2002-01-29 | — | — | US | disclosed |
| US-20010041728-A1 | Oxazolidinone antibacterial agents having a thiocarbonyl functionality | HESTER JACKSON B (US) | 2001-11-15 | — | — | US | disclosed |
| EP-1133493-A1 | OXAZOLIDINONE ANTIBACTERIAL AGENTS HAVING A THIOCARBONYL FUNCTIONALITY | PHARMACIA & UPJOHN COMPANY (US) | 2001-09-19 | — | — | EP | disclosed |
| US-6255304-B1 | AIDS THERAPY | PHARMACIA & UPJOHN COMPANY | 2001-07-03 | — | — | US | disclosed |
| WO-2000032599-A1 | OXAZOLIDINONE ANTIBACTERIAL AGENTS HAVING A THIOCARBONYL FUNCTIONALITY | PHARMACIA & UPJOHN COMPANY (US) | 2000-06-08 | — | — | WO | disclosed |
| EP-0994874-A1 | THIADIAZOLYL AND OXADIAZOLYL PHENYL OXAZOLIDINONE ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 2000-04-26 | — | — | EP | disclosed |
| US-5977373-A | Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents | PHARMACIA & UPJOHN COMPANY (US) | 1999-11-02 | — | — | US | disclosed |
| WO-1999002525-A1 | THIADIAZOLYL AND OXADIAZOLYL PHENYL OXAZOLIDINONE ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 1999-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240309024-A1 | DIRECT SYNTHESIS OF ALKENYLHALOSILANES | HRH2, HRH1, HRH3 | FFAR3 593/4885HDAC3 1439/4885HDAC1 309/4885 |
| US-20010041728-A1 | Oxazolidinone antibacterial agents having a thiocarbonyl functionality | OXA1L, MRPL21, TOP1 | FFAR3 3551/4885HDAC3 996/4885HDAC1 56/4885 |
| US-20020016323-A1 | Oxazolidinone antibacterial agents having a thiocarbonyl functionality | OXA1L, MRPL21, TOP1 | FFAR3 3551/4885HDAC3 996/4885HDAC1 56/4885 |
| US-20130065248-A1 | REAGENTS AND METHODS FOR SIRTUIN CAPTURE | SIRT3, SIRT1, SIRT2 | FFAR3 4195/4885HDAC3 11/4885HDAC1 29/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.